Weight and Healthcare • 419 implied HN points • 13 Jul 22
- The article discusses the debate over whether Type 2 Diabetes management should prioritize weight loss or blood sugar control.
- It highlights the influence of pharmaceutical companies on medical advice and guidelines in the diabetes management space.
- The article raises concerns about financial conflicts of interest, lack of long-term efficacy data, and potential risks associated with focusing on weight loss over other health factors.